PubMed Health⌕ Search

Biomedical subjects

B D Bok

Publications and source records attributed to B D Bok.

11 recordsLinked to original sources
PubMed2001

Highlights of the European Association of Nuclear Medicine Congress, Paris 2000.

The recent European Association of Nuclear Medicine Congress, "Paris 2000", was an exceptional success, as illustrated by the record attendance. This review discusses some of the key new findings presented at the Congress in the fields of neurology, cancer therapy, cancer diagnosis, cardiology and miscellaneous other areas. The progress being made indicates that nuclear medicine has a bright future in the new millennium.

Humans↗
PubMed2001

Scintigraphic screening for renal damage in siblings of children with symptomatic primary vesico-ureteric reflux.

OBJECTIVE: To define prospectively the incidence of renal parenchymal lesions in the siblings of patients treated at one institution for primary vesico-ureteric reflux (VUR). PATIENTS AND METHODS: From January 1997 to October 1998, a prospective study including renal scintigraphy (using dimercaptosuccinic acid, DMSA) and a radionuclide cystogram was proposed systematically to the asymptomatic siblings of children treated for primary VUR. The radionuclide cystograms were interpreted as showing the presence or absence of VUR and the DMSA scan as symmetrical or asymmetrical differential function, with or with no renal defect. RESULTS: Fifty-five families gave informed consent, of whom 46 completed the study (eight refused secondarily and one was omitted by exclusion criteria), representing 46 symptomatic patients and 65 siblings. There were 17 siblings with VUR (26%) including two of 13 infants and 15 of 52 children aged > 18 months. One radionuclide cystogram failed. Of the 17 refluxing siblings, four had a history of symptomatic urinary tract infection; 62 of the 65 siblings had a DMSA scan, of which 56 were normal and six (10%) showed abnormalities (five asymmetrical differential function and one parenchymal defect). Only one of these six patients had VUR at the time of the evaluation and only one had a small kidney detected by ultrasonography on one side (and no VUR). There were no adverse effects associated with screening. CONCLUSION: This study confirms a significant overall incidence of VUR (26%) in the asymptomatic siblings of patients treated for primary VUR. From the results of the DMSA scan (only one sibling had a parenchymal defect), the systematic screening of asymptomatic siblings does not appear to be beneficial.

Adolescent↗
PubMed1998

Comparison of cellular and conventional dosimetry in assessing self-dose and cross-dose delivered to the cell nucleus by electron emissions of 99mTC, 123I, 111In, 67Ga and 201T1.

The radionuclides used in nuclear medicine imaging emit numerous mono-energetic electrons responsible for dose heterogeneity at the cellular level. S(self) the self-dose per unit cumulated activity (which results from the radionuclide located in the target cell), and S(cross) the cross-dose per unit cumulated activity (which comes from the surrounding cells) delivered to a target cell nucleus by electron emissions of technetium-99m, iodine-123, indium-111, gallium-67 and thallium-201 were computed at the cellular level. An unbounded close-packed hexagonal cell arrangement was assumed, with the same amount of radioactivity per cell. Various cell sizes and subcellular distributions of radioactivity (nucleus, cytoplasm and cell membrane) were simulated. The results were compared with those obtained using conventional dosimetry. S(self) and S(cross) values depended closely on cell dimensions. While the self-dose depended on the tracer distribution, the latter affected the cross dose by less than 5%. When the tracer was on the cell membrane, the self-dose was particularly low compared to the cross-dose, as the self-dose to cross-dose ratio was always less than 11%. In the case of cytoplasmic or cell membrane distribution of radioactivity, conventional electron dosimetry slightly overestimated the dose absorbed by the target cell nucleus (by 1.08-to 1.7-fold). In contrast, conventional dosimetry strongly underestimated the absorbed dose (1.1- to 75-fold) when the radioactivity was located in the nucleus. The discrepancies between conventional and cellular dosimetry call for calculations at the cellular level for a better understanding of the biological effects of radionuclides used in diagnostic imaging.

Algorithms↗
PubMed1997

Heterogeneous distribution of technetium-99m-labeled microspheres in rat lungs: microautoradiographic evidence and dosimetric consequences.

UNLABELLED: The heterogeneity of 99mTc-labeled microspheres distribution within rat lung was visualized and quantified using a microautoradiographic "track" method (MAR). METHODS: MAR was used to study the uptake of radioactivity by individual microspheres, thereby enabling calculation of the range of particle activity. MAR was also used to visualize in rat lung sections the intrapulmonary distribution of the microspheres within the lungs after intravenous administration. The mean doses delivered to the cells in close contact with the labeled microspheres were calculated taking only the 99mTc electron emissions into account. RESULTS: All the microspheres were labeled. Nevertheless, the spectrum of visible tracks varied by a factor of 10, inducing a variable activity per microsphere from < 36 Bq to 325 Bq (mean activity-94 Bq/microsphere). No correlation existed between the radioactivity uptake and the size of microspheres. A very heterogeneous tridimensional distribution of the microspheres within the lungs were demonstrated with interparticle distances ranging from 57-4400 microns. On the other hand, only 1 of 2000 rat lung capillaries was obstructed. Using the mean activity, calculated delivered doses were found to reach approximately 6 Gy for the closest endothelial cells and 2 Gy for epithelial cells. However, such high doses were delivered to only a few cells. CONCLUSION: The number of obstructed capillaries in human lungs is lower than in rat lungs; the distances between microspheres should be larger. Nevertheless, the individual doses absorbed by the pulmonary cells closest to the microspheres should be very important.

Animals↗
PubMed1996

Nuclear medicine and cardiology: the position of the Union of European Medical Specialists/Section of Nuclear Medicine.

This paper summarizes a communication presented at the Second International Conference of Nuclear Cardiology, held in Cannes on 23-26 April 1995. The general evolution of nuclear medicine in Europe is examined within the context of European Union Directives, and the role of the Union of European Medical Specialists/Section of Nuclear Medicine is discussed. Thereafter consideration is given to the technical aspects of cardiovascular nuclear medicine procedures, and the situation with respect to such procedures in European countries is examined. In most European countries, nuclear medicine is a recognized specialty, while "nuclear cardiology" does not exist in its own right. In general, only nuclear medicine specialists have the responsibility for radionuclide studies, and most cardiovascular studies are performed under the direct responsibility of a licensed nuclear medicine specialist.

Cardiology↗
PubMed1996

Absorbed fraction to the cell nucleus for low energy electrons.

The absorbed fraction phi to the cell nucleus for low energy electrons (0.5 keV-50 keV) was evaluated. Distributions of radioactivity within either the nucleus (nu) and the cytoplasm (cy), or on the cell membrane (mem) were considered. phi was computed as a function of the cell sizes and of the electron energy E. For a strictly intranuclear distribution, phi(nu) is close to 1 for very low energy values (E < 4 keV), i.e. the energy is totally absorbed in the cell nucleus itself. The absorbed fraction decreases when the energy increases and phi(nu) becomes less than 0.1 for E > or = 40 keV. For a cell membrane distribution, the absorbed fraction remains always less than 0.2. For very low energy electrons (E < 6 keV), phi(mem) = 0, due to the fact that the electron falls short to the nucleus target. The absorbed fraction is maximum for E ranging from 12 keV to 20 keV. For higher values of E, phi(mem) decreases when E increases. When considering a cytoplasmic distribution, the maximum absorbed fraction phi(cy) is obtained for E values ranging from 10 keV to 25 keV (phi(cy max) = 0.27). Dosimetric computations at the cellular level show that the absorbed fraction to the cell nucleus may have values ranging from 0 to 1, depending on the dimensions of the cell, the energy of the emitted electron and on the intracellular localization of the Auger emitter.

Absorption↗
PubMed1995

Modelling of the relationship between cell dimensions and mean electron dose delivered to the cell nucleus: application to five radionuclides used in nuclear medicine.

The mean dose delivered to the cell nucleus by electron emissions of 99Tcm, 123I, 111In, 67Ga and 201Tl was evaluated at the subcellular level. Models were applied assuming uniform distributions of radioactivity throughout the nucleus, the cytoplasm or the cell membrane, allowing computation of the total absorbed fraction, phi and S-values to the cell nucleus as a function of cell dimensions. The graphs of phi plotted according to cell dimensions show that the dose to the cell nucleus strongly depends on the subcellular distribution of radioactivity, the nucleus radius Rnucl and the cytoplasmic thickness e. For a nuclear distribution, phi ranges from 0.1 to 0.35 for the radionuclides studied and S from 0.049 cGy Bq-1 s-1 to 5.503 cGy Bq-1 s-1. In the case of a cell membrane localization, the maximum is obtained for 123I (phi = 0.016). For a cytoplasmic distribution, the maximum is obtained for 201Tl with a value of 0.036. To ease future calculations, third-degree polynomials have been separately fitted to the relationship between the mean absorbed dose to the nucleus for activity accumulated in the nucleus, cytoplasm or surface of the cell membrane. We found a good agreement between our computations and the values obtained by the polynomials. The relative difference between the two methods is always less than 0.7%, 2.8% and 4.5% respectively for nuclear, cell membrane and cytoplasmic distributions.

Cell Membrane↗
PubMed1994

The influence of tracer localization on the electron dose rate delivered to the cell nucleus.

UNLABELLED: The radiation dose rate delivered by electron emissions of 99mTc, 123I, 111In, 67Ga and 201Tl was evaluated at the subcellular level. METHODS: Spherical models of sources were used to simulate various cellular localizations of radionuclides. These models were applied to large lymphocytes, assuming uniform distributions of radioactivity throughout the nucleus, the cytoplasm or the cell membrane surface. RESULTS: The graphs of the absorbed dose rate plotted according to the distance from the center of the cell show that the dose rate strongly depends on the subcellular distribution of the radioisotope. The absorbed dose rate D(0) at the center of the cell delivered by a constant cellular radioactivity of 99mTc, 123I, 111In, 67Ga and 201Tl is respectively 94, 21, 18, 74 and 76 times higher if the radioactivity is localized within the cell nucleus than if it is situated only on the cell membrane. D(0) for subcellular localizations was compared to D(0) obtained by assuming uniform distribution of radioactivity throughout the cell. This latter assumption may underestimate the dose rate from 2.8- to 3.2-fold if the tracer is exclusively localized within the nucleus or overestimate from 4.3- to 30-fold if the tracer is localized within the cytoplasm or on the cell membrane, depending on the radionuclide. CONCLUSION: Such findings show that the localization of radiopharmaceuticals at the subcellular level plays a crucial role in determining the actual dose delivered to the cell nucleus in diagnostic nuclear medicine procedures.

Cell Membrane↗
PubMed1987

Artifacts in camera based single photon emission tomography due to time activity variation.

Image quality in single photon emission computed tomography (SPECT) using a rotating gamma camera is dependent on the time course of the tracer in the field of view. If acquisition times are slow compared to the tracer turnover, artifacts may occur in the reconstructed images. The properties of such artifacts were studied by computer simulation. Experimental projection data of point sources, cylindrical phantoms, and an anatomically realistic brain phantom were altered by sequentially weighting the projections with a function that varied exponentially or linearly with time. The observed distortion in the reconstructed images could be related to the ratio between the object activity variation and the camera rotation time. If the tracer concentration changed less than a factor of two during one camera rotation then little image distortion was visible although quantitatively the resolution was degraded. If the object's activity variation with time is fast enough to produce noticeable distortion, the artifacts can be reduced by performing multiple, rapid, camera rotations, instead of one rotation, for the same total acquisition time. The proposed procedure is computer storage space intensive and takes longer to produce the transaxial images, but improves image quality.

Image Enhancement↗
PubMed1987

Comparison of 99Tcm complexes (NEP-DADT, ME-NEP-DADT and HMPAO) with 123IAMP for brain SPECT imaging in dogs.

Several new lipophilic 99Tcm complexes have recently been described as alternatives to N-isopropyl (123I) iodoamphetamine (123IAMP) for measurement of regional cerebral blood flow (RCBF). In this study we have compared brain uptake and blood clearance of 99Tcm-N-ethylpiperidine-diamino dithiol (99Tcm-NEP DADT), its 4-methylated derivative (99Tcm-Me-NEP-DADT) and 99Tcm-hexamethyl-propylene-amine-oxime (99Tcm-HMPAO) with that of 123IAMP in two dogs. Single photon emission tomography (SPECT) was employed to measure brain accumulation and retention of the four radiopharmaceuticals. Cerebral uptake of the 99Tcm complexes (0.8-1.1%) was lower than that of 123IAMP (1.6% of the injected dose). There was considerable extracerebral activity in the dog's head, especially in the olfactory and snout regions. Because of slow blood clearance 99Tcm-HMPAO showed high uptake in these regions. Brain uptake of 99Tcm-HMPAO reached a plateau 5 to 10 min after intravenous injection and remained constant for the entire study period (1 h). 99Tcm-NEP-DADT, on the other hand, showed significant clearance from the brain after reaching maximal uptake at 10 to 15 min after injection. However, brain imaging with these agents was possible during the first 20 min. The mechanism of brain uptake, as well as the relationship between brain uptake and RCBF need to be evaluated for each of the four radiopharmaceuticals.

Amphetamines↗